PE-backed Imprivata raises $75 mln for IPO

Imprivata has rolled out its IPO after pricing its 5 million shares at $15 per share. The stock began trading Wednesday on the NYSE under the ticker symbol “IMPR.” JP Morgan and Piper Jaffray are the lead underwriters. Headquartered in Lexington, Mass., Imprivata is a provider of authentication and access management solutions for the healthcare sector. Its backers include General Catalyst Partners, Highland Capital Partners and Polaris Partners.


Lexington, Mass.—June 24, 2014—Imprivata® (NYSE: IMPR) today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $15.00 per share. The shares are expected to begin trading on the New York Stock Exchange under the symbol “IMPR” on June 25, 2014. In addition, Imprivata has granted the underwriters a 30-day option to purchase up to 750,000 additional shares of common stock from Imprivata at the initial public offering price to cover over-allotments, if any. All of the common stock is being offered by Imprivata.

J.P. Morgan and Piper Jaffray are acting as joint book-running managers for the offering. William Blair, Wells Fargo Securities and Stephens Inc. are acting as co-managers.

A registration statement relating to these securities has been filed with and was declared effective by the Securities and Exchange Commission on June 24, 2014. This offering is made only by means of a prospectus. When available, you may request a copy of the final prospectus relating to this offering by contacting: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or Piper Jaffray & Co., 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, or by telephone at (800) 747-3924, or by e-mail at

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Imprivata
Imprivata is a leading provider of authentication and access management solutions for the healthcare industry. Imprivata’s single sign-on, authentication management and secure communications solutions enable fast, secure and more efficient access to healthcare information technology systems to address multiple security challenges and improve provider productivity for better focus on patient care. For more information, please visit